by heshamhamed | Nov 1, 2022 | News
One or more representatives from Adoram Therapeutics will be attending the events listed below. Please feel free reach out via the contact form, email, or linkedin, if you would like to organize a meeting there. November: Swiss Oncology and Hematology...
by heshamhamed | Oct 13, 2022 | News
Co-founders David Pejoski and Hesham Hamed will attend one of the premier biotech partnering events in Europe, the autumn edition of BioEurope, to be held in Leipzig Germany between the 24th and 26th October 2022. This networking event brings together young biotech...
by heshamhamed | Aug 11, 2022 | News
Adoram Therapeutics has recently been accepted into the Swiss Biotech Association. Our Swiss Biotech company page and Venture Platform listing (for business partnering and investor interactions) can found here Adoram Therapeutics SA...
by heshamhamed | Jun 1, 2022 | News
The management team are pleased to announce the incorporation of Adoram Therapeutics SA in the Canton of Geneva in Switzerland. The co-founding team created the biotech company as a Spin-Off from the University of Geneva in order to pursue their passion in addressing...
